ACARIX: Acarix AB (publ) - Summary | Jitta

Acarix AB (publ)

SWE:ACARIX

Price
kr0.27
Loss Chance
50.8%
3.60JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
15 / 107
142 / 616
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (61)
Recent Business Performance (53)
Financial Strength (38)
Return to Shareholders (0)
Competitive Advantage (54)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
SG&A to SalesDecreasing
Revenue and EarningEarning loss detected in 2025
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
3.60
100.00%
2.89
152.39%
Health Care Equipment
4.20
6.02%
3.04
26.59%
4.04
49.77%
COMPANY DESCRIPTION
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to support clinical decision making at the point of care. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.